BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29303624)

  • 1. Optimization of Risk Stratification in Localized Prostate Cancer.
    Morgans AK
    J Clin Oncol; 2018 Feb; 36(6):528-532. PubMed ID: 29303624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate Cancer Radiotherapy: An Evolving Paradigm.
    Catton CN; Lukka H; Martin J
    J Clin Oncol; 2018 Oct; 36(29):2909-2913. PubMed ID: 30138084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating Androgen Deprivation With Dose-Escalated External-Beam Radiotherapy for Prostate Cancer.
    Dosoretz AP; Yu JB
    J Clin Oncol; 2016 May; 34(15):1718-22. PubMed ID: 27001587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy.
    Zumsteg ZS; Daskivich TJ; Sandler HM
    J Clin Oncol; 2016 Nov; 34(32):3829-3833. PubMed ID: 27573664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To treat or not to treat, that is the question: the role of bone-targeted therapy in metastatic prostate cancer.
    Higano CS
    J Clin Oncol; 2014 Apr; 32(11):1107-11. PubMed ID: 24590651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Younger Man With Localized Prostate Cancer Asks, "Which Type of Radiation Is Right for Me?".
    Bekelman JE
    J Clin Oncol; 2018 Jun; 36(18):1780-1784. PubMed ID: 29718792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
    Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
    Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing Is Everything: What Is the Optimal Duration After Chemoradiation for Surgery for Rectal Cancer?
    Goodman KA
    J Clin Oncol; 2016 Nov; 34(31):3724-3728. PubMed ID: 27601550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feeding the Controversy: When Pelvic Irradiation Improves Outcomes in High-Risk and Very High-Risk Prostate Cancer.
    Jan I; Parikh RR
    J Clin Oncol; 2021 Apr; 39(11):1196-1202. PubMed ID: 33683923
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted Therapy for Metastatic Urothelial Cancer: A Work in Progress.
    Plimack ER; Geynisman DM
    J Clin Oncol; 2016 Jun; 34(18):2088-92. PubMed ID: 27161964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isn't Androgen Deprivation Enough? Optimal Treatment for Newly Diagnosed Metastatic Prostate Cancer.
    Morgans AK; Beltran H
    J Clin Oncol; 2022 Mar; 40(8):818-824. PubMed ID: 34990290
    [No Abstract]   [Full Text] [Related]  

  • 13. Duration of Anti-Programmed Death-1 Therapy in Advanced Melanoma: How Much of a Good Thing Is Enough?
    Khushalani NI
    J Clin Oncol; 2018 Jun; 36(17):1649-1653. PubMed ID: 29389234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
    Gilligan T
    J Clin Oncol; 2016 Feb; 34(4):303-6. PubMed ID: 26668343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
    KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H
    BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.
    Lee DH; Nam JK; Park SW; Lee SS; Han JY; Lee SD; Lee JW; Chung MK
    Yonsei Med J; 2016 May; 57(3):565-71. PubMed ID: 26996553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer.
    Rosenzweig KE; Gomez JE
    J Clin Oncol; 2017 Jan; 35(1):6-10. PubMed ID: 27870565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Infiltrates in a Patient With Advanced Melanoma.
    Powell CA
    J Clin Oncol; 2017 Mar; 35(7):705-708. PubMed ID: 28029320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.
    Voss J; Pal R; Ahmed S; Hannah M; Jaulim A; Walton T
    BJU Int; 2018 Jun; 121(6):863-870. PubMed ID: 29239082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.